相关实验视频
Updated: Jan 12, 2026
09:22
Sectioning Mammary Gland Whole Mounts for Lesion Identification
Published on: July 24, 2017
11.1K
在怀孕期间暴露于基-3和乳腺分化时,发育并没有改变
Ayelen L Gomez1, Sofia Oddi2, María B Beckley2
1Instituto de Salud y Ambiente del Litoral (ISAL. UNL-CONICET), Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina; Cátedra de Patología Humana, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Chemico-biological interactions
|November 1, 2025
概括
在小鼠或细胞模型中,相-3 (BP3) 暴露没有影响乳腺内置. 在这个关键的产后过程中,这种紫外线过器没有改变组织重塑,细胞亡或脂肪生成.
科学领域:
- 生殖生物学和毒理学.
- 哺乳腺的发育和进化.
- 内分泌干扰和环境化学物质
背景情况:
- 乳腺内置是一种复杂的组织重塑过程,对于停止哺乳和预防疾病至关重要.
- 基-3 (BP3) 是一种常见的紫外线过器,具有内分泌干扰的特性,包括雌激素和亲子亡活动.
- 对于BP3对乳腺内置的潜在干扰,人们对生殖健康和瘤易感性表示担忧.
研究的目的:
- 为了研究相-3 (BP3) 暴露对乳腺发育的影响.
- 通过体内小鼠模型和体外细胞培养系统来评估BP3的影响.
- 评估BP3对内进化的关键过程的影响,包括细胞亡和 stromal重塑.
主要方法:
- 在体内:怀孕的小鼠在怀孕期间通过皮肤暴露于BP3 (5或50毫克/公斤/天) 或载体;乳腺在断奶后收集.
- 在体外: HC11乳腺上皮细胞和3T3-L1前腺细胞在分化和激素戒断阶段用BP3治疗.
- 分析包括亡试验,基因表达概况 (亡,脂肪生成,重塑标记物) 以及组织和细胞形态的评估.
主要成果:
- 在体内或体外,暴露于BP3并没有显著改变乳腺膜区域,亡率或关键亡相关基因 (Stat3,Bax,Igfbp5,Bcl2) 的表达.
- 流体重塑标记物,包括原沉积和脂肪细胞区域在体内,不受BP3的影响.
- BP3没有影响分化脂肪细胞中的脂质积累,也没有改变脂肪生成和重塑基因的表达 (利平素1,利平素2,Pparγ,脂肪酸合成酶,MMP3).
结论:
- 在经过测试的条件和剂量下,在怀孕期间或乳腺细胞分化期间暴露于三 (BP3) 不会扰乱乳腺发育.
- 该研究表明,BP3不会干扰乳腺组织重塑和进化过程中的亡的生理过程.
- 进一步的研究可能是有必要的,以探索不同暴露水平或时间的潜在影响,或其他乳腺功能.
相关概念视频
02:30Genomic Imprinting and Inheritance
36.8K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.8K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:22Development of Immunocompetence
781
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
781